| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44027303 | HTLV-1 | ENSG00000140675.13 | protein_coding | SLC5A2 | No | No | 6524 | P31639 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC5A2 |
|---|---|
| DrugBank ID | DB06292 |
| Drug Name | Dapagliflozin |
| Target ID | BE0004753 |
| UniProt ID | P31639 |
| Regulation Type | antagonist |
| PubMed IDs | 19996149 |
| Citations | Obermeier M, Yao M, Khanna A, Koplowitz B, Zhu M, Li W, Komoroski B, Kasichayanula S, Discenza L, Washburn W, Meng W, Ellsworth BA, Whaley JM, Humphreys WG: In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans. Drug Metab Dispos. 2010 Mar;38(3):405-14. doi: 10.1124/dmd.109.029165. Epub 2009 Dec 8. |
| Groups | Approved |
| Direct Classification | Phenolic glycosides |
| SMILES | CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL429910 |
